Investors who are current long-term stockholders of shares of Insmed Incorporated (NASDAQ:INSM)
The investigation by a law firm focuses on whether certain directors and officers of Insmed Incorporated harmed the company by agreeing to pay certain of Insmed’s senior officers and executives improper compensation.
Insmed Incorporated reported that its annual Revenue declined from $10.37 million in 2009 to $6.92 million in 2010 and $4.42 million in 2011 and its Net Income of $11.8,35 million in 2009 decreased to a Net Loss of $6.43 million in 2010 and $59.66 million in 2011.
The Total Compensation of certain top officials at Insmed Incorporated increased from 2010 to 2011. For instance the Executive VO and CFO’s pay increased from over $389,000 in 2010 to over $1.01 million in 2011 and the Chief Scientific Officer’s compensation rose from over $401,000 in 2010 to over $836,000 in 2011.
Shares of Insmed Incorporated (NASDAQ:INSM)
On Jan. 17, 2013, NASDAQ:INSM shares closed at $6.55 per share.
Those who are current long-term stockholders of Insmed Incorporated (NASDAQ:INSM)